Aruvant to Present at Investor and Scientific Conferences in October

NEW YORK and BASEL, Switzerland, Sept. 29, 2020 /PRNewswire/ -- Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative gene therapies for the treatment of rare diseases, today announced it will present at multiple conferences in...